TypeOnline Course
Student Enrolled5
(1 ratings)
Price$790 / Rs. 38500
Buy NowBook Now

Admission Process

Admission Process

Sign in or create account at www.nckpharma.com with all details and make the course fees payment to start the course

Sign Up Now

Course Code: KPE-C-023N

Course Title: KPE’s Advance Diploma in Pharmaceutical Product Management and Regulatory Affairs (Dual Specialization)

Course Objective: B.Pharm/D.Pharm/ B.Sc/ Any graduates or those who are in 3rd / final year of those courses, who want to make career in pharmaceutical Product Management and Regulatory Affairs can pursue the course.

Features of the Course:

1. Comprehensive study material covering all important aspects of Pharmaceutical Product Management and Regulatory Affairs

2. Understanding/ Decision Making/ Strategy Creation in the field of Pharma Brand Management, Pharma Marketing, international marketing and regulatory affairs.

3. Pharma Marketing & Regulatory Affairs Case Study File for effective skill enhancement for strategic decision making

4. Specialized modules on International Marketing of Pharmaceutical Products and Strategic Management

Course Duration: 1 Year

Nature of the Course: Distance & e-Learning

Certificates: Two separate certificate (for drug regulatory affairs and pharmaceutical product management) will be provided.

Course Flow : Course covers comprehensively total regulatory affairs syllabus and pharma product management syllabus.

Section 1Fundamental of Drug Discovery, Development (US Regulation)
Lecture 1Introduction to R&D Process & drug discovery
Lecture 2Investigational New Drug Application
Lecture 3New Drug Application (NDA)
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA)
Lecture 6Complete Response Letter | Key understanding | Management and Action Plan
Lecture 7Generic Drug User Fees Act (GDUFA)
Lecture 8Prescription Drug User Fees Act (PDUFA)
Lecture 9Handling of orange book
Lecture 10USFDA Expedited Programs (Detailed Understanding)
Lecture 11Practical Training on INDA, NDA, ANDA filing
Lecture 12505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 13Authorized Generics: Key Understanding
Lecture 14Exploratory IND Vs. Traditional IND
Lecture 15Patents Vs. exclusivity
Lecture 16Learning from New Drug Approvals
Lecture 17Orphan Drug & Orphan Drug Act
Lecture 18Advance Learning on 505B2 Pathway
Lecture 19Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 20Review on Drug Discovery and Development 
Section 2Clinical Trial / Research - Fundamental
Lecture 21Clinical Trials Terminologies
Lecture 22Clinical Trial Protocol Writing
Lecture 23Ethics in Clinical Research
Lecture 24Informed Consent
Lecture 25FDA Forms and How to fill the resources
Lecture 26Strategic Discussion: PreIND, EOP1, EOP2 - What to expect !
Section 3IPR Related Topics (Optional)
Lecture 27USPTO - Introduction
Lecture 28Patent - Fundamental Concepts
Lecture 29Patent Application Process - USPTO
Lecture 30Trademark Search and Registration in US
Lecture 31Steps Know How & Key Points - Patent Application
Lecture 32IPR - Patent Grant and Handling Process in India (Optional)
Lecture 33Patent - Practical on search and filing in Indian Patent Office (Optional)
Lecture 34Trademark - Practical on TM Search & Registration Process in India (Optional)
Lecture 35Trademark Search assignment (India) - (Optional)
Lecture 36Fundamental Understanding of Patent, Trademark Licensing and related terminology
Section 4Regulatory Strategies
Lecture 37Regulatory Strategies
Lecture 38Advance study on Para IV Filing
Lecture 39Para IV Notices
Lecture 40Evergreening - Patent Life Extension Strategies
Lecture 41Pay For Delay Strategy
Lecture 42REMS Strategic Planning 
Lecture 43Compulsory Licensing
Lecture 44Technology Licensing
Lecture 45In-Licensing Vs. Outlicensing
Lecture 46LOE Strategies for Innovator Brands with case study
Lecture 47Paediatric Exclusivity and Paediatric Study Plan Development
Lecture 48Drug Repurposing
Section 5GMP
Lecture 49Definition of GMP
Lecture 50Certification Pharmaceutical Companies / Plants
Lecture 51Introduction to Good Manufacturing Practices
Lecture 52G1 Lecture Premises & Plant Layout Designing
Lecture 53G2 Lecture Sanitation and Hygiene
Lecture 54G3 Lecture Equipment Modules
Lecture 55G4 Lecture Production Modules
Lecture 56G5 Lecture Documentation
Lecture 57G6 Lecture Quality Control
Lecture 58G7 Lecture Product Complaint
Lecture 59G8 Lecture Storage Module
Lecture 60ISO and ISO Audits
Lecture 61Pharmaceutical SOPs
Lecture 62SOP Automation in Pharmaceutical Industry
Section 6DMF & SMF
Lecture 63Key Consideration for Drug Master File Preparation and Submission 
Lecture 64Practical Understanding on Drug Master File Preparation and Submission
Lecture 65Practical Training on preparing DMF and SMF
Lecture 66DMF Completeness Assessment
Lecture 67Drug Master File - Fees
Lecture 68Drug Master File - Global Perspective [Across Different Regions]
Section 7Biosimilar
Lecture 69Biosimilar
Lecture 70Biosimilar Approval process
Lecture 71Biological Licensing Application (BLA)
Lecture 72Vaccine development and approval Process
Section 8USFDA warning Letter & CAPA
Lecture 73Data Integrity issues in Pharmaceutical Industry
Lecture 74Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 75Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Section 9Drug Registration in European Country (Optional)
Lecture 76Introduction to EU Regulation
Lecture 77Orientation to European Countries and National Regulatory Bodies
Lecture 78Overview of EU Regulation
Lecture 79EMEA Procedures
Lecture 80Summary of Product Characteristics
Lecture 81Compassionate Use
Lecture 82MHRA - UK Regulation
Lecture 83EU Orphan Medicinal Products Regulation
Section 10GCC Drug Regulatory Affairs
Lecture 84Regions in Pharma Business : Common Terminologies
Lecture 85GCC Pharma Market
Lecture 86GCC Export
Lecture 87GCC Registration Procedure
Lecture 88Drug Registration in Saudi Arabia
Lecture 89Documentation Required for the GCC countries
Lecture 90Drug Registration in GCC countries
Lecture 91Medical Device Regulation in GCC countries
Section 11Drug Registration Dossier
Lecture 92Introduction to Common Technical Document (CTD)
Lecture 93Asean Common Technical Document (ACTD)
Lecture 94Introduction to Electronic Common Technical Document (ECTD)
Lecture 95Advance Practical Training on Dossier Preparation focusing on drug registration in export countries
Lecture 96Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 97Chemistry, Manufacturing & Controls - Fundamental Understanding 
Lecture 98CMC Dossier & Compliance Management
Lecture 99Black Box Warning
Lecture 100Importance of effective dossier management
Lecture 101Deficiencies observed in CTD Dossiers
Lecture 102Certificate of Analysis
Lecture 103Detailed Understanding on ANDA Submission Dossier 
Lecture 104Prior Approval Submission 
Lecture 105Detailed Understanding on ANDA Fees
Lecture 106Detailed Understanding on 505(b)(2) VS. Suitability Petition : Case Based Learning
Lecture 107NCE Vs. 505b2 application - Case Based Learning 
Lecture 108FTF - 180 Days Exclusivity - Case Based Learning
Lecture 109Classic case study of the 505b2 filing : Case Based Learning
Lecture 110Discussion on 85 common deficiency in CTD submission dossier
Lecture 111Data Integrity issues in Pharmaceutical Industry
Section 12ASEAN Drug Regulatory Affairs
Lecture 112Introduction
Lecture 113Asean Geography
Lecture 114Drug Registration in Brunei
Lecture 115Drug Registration in Malaysia
Lecture 116Drug Registration in Cambodia
Lecture 117Drug Registration in Mayanmar
Lecture 118Drug Registration in Philippines
Lecture 119Drug Registration in Singapore
Section 13Drug Regulation in India - CDSCO
Lecture 120Drug Regulation in India - CDSCO
Lecture 121National Pharmaceutical Pricing Authority
Lecture 122Drug Price Regulation in India
Lecture 123Drug Registration in India - Practical understanding drug registration process in CDSCO
Lecture 124Drug Price Control Order 2013
Lecture 125Case Study of New Drug Approval in India
Section 14Introduction: Pharma Product Management
Lecture 126Career in Pharma Product Management
Lecture 127Detailed Understanding of Product Management Job
Section 15Fundamentals of Pharma Marketing
Lecture 128Marketing Orientation for Product Manager
Lecture 129Why Is Market Research Important in Pharmaceutical Business?
Lecture 130Product Life cycle - Basic Understanding
Lecture 131Concept of STP
Lecture 132Pricing
Lecture 133Distribution Channel in Pharmaceutical Industry 
Lecture 134Promotion in Pharmaceutical Industry : Communication Model, Effective promotional communication, Push Vs. Pull Strategy and Buying Decision Process
Lecture 135A Pharmaceutical Segmentation outlook
Lecture 136Practical understanding on Prescription Accelerating Materials used in pharmaceutical promotion
Lecture 137Method of Promotional Budgeting
Lecture 138Basics of Advertising : Introduction
Lecture 139The Advertising agency Selection Process with Case Based Learning on Creative Brief Preparation
Lecture 140Brand Recall | Brand Recognition |Top of mind - How to calculate brand recall value?
Lecture 141Advertising Planning - ATL, BTL, TTL activities
Section 16Practical Training on Pharma Brand Logo Development
Lecture 142Brand Logo - Introduction
Lecture 143Purpose of Brand Logo
Lecture 144Component of Brand Logo
Lecture 145Brand Name and TM Registration Process
Lecture 146Trademark - Practical on TM Search
Lecture 147Trademark Search assignment
Lecture 148Trademark Registration in US
Lecture 149How to design excellent brand logo?
Lecture 150Color Systems - RGB & CMYK
Lecture 151Few Case Studies related to brand names and logos
Lecture 152Brand Logo - Simulation
Lecture 153Colour Trademarking in Pharma Branding
Lecture 154How to protect pharma brands globally?
Lecture 155Rebranding Exercise in Pharmaceutical Industry
Lecture 156Brand Logo Development: Real Life Simulation
Section 17Marketing Plan / Brand Plan Fundamentals
Lecture 157 Basic Understanding how to launch a pharmaceutical product into the market
Lecture 158Marketing Campaign Development
Lecture 159How to prepare a Pharma Brand Plan
Lecture 160Marketing Plan : Sample Plan - Glimiperide + Metformin
Lecture 161Decide about brand USP -What to promote
Lecture 162How to prepare promotogram. Download sample Promotogram
Lecture 163Importance and Handling of Cycle Meeting and its importance
Lecture 164Sample Marketing Plan : Febuxostat
Lecture 165Sample Marketing Plan : Pregabalin
Lecture 166Sample Marketing Plan : Pregabalin
Lecture 167New Product Launch Case Study
Lecture 168Aristada - Launch Case Study
Lecture 169CSR Campaign
Lecture 170Sample Allocation Planning
Section 18Practical Training on Visual Aid Development
Lecture 171Importance of Visual Aid in Pharma Industry
Lecture 172Fundamentals of preparing visual aid
Lecture 173Indications for Drugs: Approved vs. Non-approved
Lecture 174Case Study : Indication approval to extend the usage of the brands (molecule)
Lecture 175Step by step visual aid development process
Lecture 176Guideline of Visual Aid Designing
Lecture 177Practical Sample to understand visual aid contents and effective placement of the texts
Lecture 178Visual Aid Printing
Lecture 179Detailing and e-detailing
Lecture 180Visual Aid Development
Lecture 181Visual Aid, Literature reference Sample
Lecture 182Tablet vs. Conventional Detailing
Section 19Practical Training on Packaging Development
Lecture 183Artwork Development Process in PMT Department
Lecture 184Product List and Reminder card development
Lecture 185Catch Cover Development
Lecture 186Packaging Development
Lecture 187Prescribing Information and Patient Information Leaflet development
Lecture 188Pharma Packaging Case Studies
Section 20Analytics
Lecture 189Moving annual total (MAT)
Lecture 190Compound Annual Growth Rate (CAGR)
Lecture 191Analytical Approach in Determining Brand Potential with case study
Section 21Strategic Sessions
Lecture 192Co-promotion & Co-marketing strategy
Lecture 193Concept of Reverse co-promotion in pharma industry
Lecture 194In-Licensing Vs. Outlicensing
Lecture 195Importance of Publications in Pharmaceutical Industry
Lecture 196Juxtapid Case Study
Lecture 197New Indication Approval Process and Promotion
Section 22Basic Finance for Pharma managers
Section 23Case Study Directory
Section 24Marketing Strategy Related Sessions
Lecture 200Increase the brand reach with advance segmentation
Lecture 201Concept of uniform branding for better brand acceptability
Lecture 202Brand Line Extension : Importance and Strategic Planning 
Lecture 203Disease Awareness Campaign - Brand Building Activities on Specific Health Day
Lecture 204Medical Animation for Brand Building 
Lecture 205Celebrity Endorsement in Pharmaceutical Brand Promotion
Lecture 206Celebrity Endorsement Vs. Bootlegging 
Lecture 207Promotion Advertisement Regulations
Lecture 208Importance of Sponsoring Medical Conference: Promotion of Pharmaceutical Brands in Medical Conferences
Lecture 209Conference Banner Designing
Lecture 210Roll Up Standee